Dental treatment in patients with severe gag reflex using propofol-remifentanil intravenous sedation.
10.17245/jdapm.2017.17.1.65
- Author:
Sooil SHIN
1
;
Seungoh KIM
Author Information
1. Department of Advanced General Dentistry, School of Dentistry, Dankook University, Cheonan, Korea.
- Publication Type:Case Report
- Keywords:
Dental Care;
Gagging;
Propofol;
Remifentanil;
Sedation
- MeSH:
Anesthesia, General;
Antiemetics;
Deep Sedation;
Dental Care;
Dentists;
Gagging;
Humans;
Hypnotics and Sedatives;
Propofol;
Reflex*
- From:Journal of Dental Anesthesia and Pain Medicine
2017;17(1):65-69
- CountryRepublic of Korea
- Language:English
-
Abstract:
Patients with severe gag reflex (SGR) have difficulty getting the treatment they require in local clinics, and many tend to postpone the start of their treatment. To address this problem, dentists have used behavioral techniques and/or pharmacological techniques for treatment. Among the pharmacological methods available, propofol IV sedation is preferred over general anesthesia because it is a simpler procedure. Propofol in combination with remifentanil is characterized by stable sedative effects and quick recovery, leading to a deep sedation. Remifentanil acts to reduce the pain caused by lipid-soluble propofol on injection. The synergistic effects of propofol-remifentanil include reduction in the total amount of drug required to achieve a desired sedation level and anti-emetic effects. In this case report, we outline how the use of propofol-remifentanil IV sedation enabled us to successfully complete a wide range of dental treatments in a patient with SGR.
